About Glaxosmithkline Asia Private Limited
Data last updated: 25 February 2026
Glaxosmithkline Asia Private Limited is a private limited company based in Patiala, Punjab, India, a subsidiary of Haleon Uk Services Limited. It specialises in ayurvedic products and services, a part of the broader healthcare sector. Incorporated on 18 October 1995, the company has been in operation for over 31 years.
Registered with ROC Chandigarh under CIN U99999PB1995PTC028476.
Capital: an authorised share capital of ₹10 Cr and a paid-up capital of ₹5.5 Cr. It is led by directors including Nitin Mathur and Anurita Chopra.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Patiala Road Nabha, Punjab, India – 147201.
As per the financials filed for FY 2023, the company reported a revenue of ₹2,361.58 Cr, a growth of 15.62% compared to the previous year.
The company has a workforce of approximately 789 employees as per the latest available data. It operates as a subsidiary of Haleon Uk Services Limited.
The company is associated with 2 brands - Centrumshop, Gsk.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website gsk.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social MediaLocked
-
Registered AddressPatiala Road Nabha, Punjab, India – 147201
-
IndustryHealthcare, Ayurvedic Products & Services
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Glaxosmithkline Asia Private Limited
Glaxosmithkline Asia Private Limited has one previous CIN (Corporate Identification Number): U99999PB2005PTC028476. The current CIN is U99999PB1995PTC028476, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U99999PB1995PTC028476 | Current |
| U99999PB2005PTC028476 | Previous |
Associated Brands with Glaxosmithkline Asia Private Limited
Glaxosmithkline Asia Private Limited operates two associated brands: Centrumshop and GSK. These brands represent Glaxosmithkline Asia Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Nutritional supplements and multivitamins for health support in India. | centrumshop.in | |
| Developer of pharmaceuticals and vaccines for various therapeutic areas | gsk.com |
Competitors & Alternatives of Glaxosmithkline Asia Private Limited
Brands and companies operating in the same space as Glaxosmithkline Asia Private Limited include Merck, Roivant Sciences, AbbVie and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Merck
|
Pharmaceutical products are manufactured and marketed worldwide. | Kenilworth, United Kingdom, United Kingdom | 1891 |
Roivant Sciences
|
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | New York, United States, United States | 2014 |
AbbVie
|
Biopharmaceutical research and drug development are conducted globally by AbbVie. | Chicago, United States, United States | 2012 |
Lilly
|
Traditional pharmaceutical medicines are developed for multiple health fields. | United States | 1876 |
Gilead
|
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | Foster City, United States, United States | 1987 |
Roche
|
Pharmaceuticals and diagnostics kits are developed for various diseases. | Basel, Switzerland, Switzerland | 1896 |
Avidity Biosciences
|
Antibody-siRNA complexes are developed for cancer treatment. | San Diego, United States, United States | 2012 |
MorphoSys
|
Therapeutic antibodies for cancer and other diseases are developed. | Planegg, Germany, Germany | 1992 |
Vertex Pharmaceuticals
|
Developer of drugs for the treatment of multiple disorders | United States | 1989 |
Univercells
|
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production. | Charleroi, Belgium, Belgium | 2013 |
Business Activity of Glaxosmithkline Asia Private Limited
Glaxosmithkline Asia Private Limited operates primarily in the manufacturing and trade sectors. The company has 2 registered business activity segments, reflecting its diverse operational portfolio.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Locked | Manufacturing | Locked | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
| Locked | Trade | Locked | Wholesale Trading | Locked |
Detailed business activity records for Glaxosmithkline Asia Private Limited
Activity codes and turnover contribution percentages require an active report plan.
- Activity group codes
- Detailed activity codes
- Turnover contribution
Verified entity values are shown only after access is granted.
Auditor Details of Glaxosmithkline Asia Private Limited
Glaxosmithkline Asia Private Limited is audited by Deloitte Haskins & Sells LLP for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Deloitte Haskins & Sells LLP | Locked | Locked | Locked |
Complete auditor history for Glaxosmithkline Asia Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Glaxosmithkline Asia Private Limited
Glaxosmithkline Asia Private Limited is currently managed by 4 directors, with 34 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Nitin Mathur
Also directs:
Glaxosmithkline Asia Private Limited
|
Whole-Time Director | 30 Jan 2021 | 5 Years 6 Months | Current |
|
Anurita Chopra
Also directs:
Glaxosmithkline Asia Private Limited
|
Whole-Time Director | 05 Sep 2016 | 9 Years 11 Months | Current |
|
Ramesh Chander Gupta
Also directs:
Glaxosmithkline Asia Private Limited
|
Director | 01 Oct 2008 | 17 Years 10 Months | Current |
|
Kanika Shah Wadhwa
Also directs:
Glaxosmithkline Asia Private Limited
|
Whole-Time Director | 12 Mar 2019 | 7 Years 5 Months | Current |
Financials of Glaxosmithkline Asia Private Limited FY 2025 filings available
Glaxosmithkline Asia Private Limited reported revenue of ₹2,361.58 Cr (up 15.62% YoY) for FY 2023.
Ten-year financial statements for Glaxosmithkline Asia Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Glaxosmithkline Asia Private Limited
Shareholding and ownership data for Glaxosmithkline Asia Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings Glaxosmithkline Asia Private Limited
Glaxosmithkline Asia Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Glaxosmithkline Asia Private Limited
Glaxosmithkline Asia Private Limited has a workforce of 789 employees as of Mar 27, 2024.
Employee and EPFO history for Glaxosmithkline Asia Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Glaxosmithkline Asia Private Limited
GST registrations and filing compliance for Glaxosmithkline Asia Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Glaxosmithkline Asia Private Limited
Credit ratings, litigation, and regulatory alerts for Glaxosmithkline Asia Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Glaxosmithkline Asia Private Limited
MSME payment history for Glaxosmithkline Asia Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Glaxosmithkline Asia Private Limited
Corporate group structure for Glaxosmithkline Asia Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Glaxosmithkline Asia Private Limited
MCA filings and documents for Glaxosmithkline Asia Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Glaxosmithkline Asia Private Limited
Frequently Asked Questions about Glaxosmithkline Asia Private Limited
Glaxosmithkline Asia Private Limited is an active private limited company in the healthcare sector based in Patiala, Punjab, India. It was incorporated on 18 October 1995 (31+ years old) and is registered under CIN U99999PB1995PTC028476. The company has 789 employees.
Glaxosmithkline Asia Private Limited reported revenue of ₹2,361.58 Cr for FY 2023 (up 15.62% YoY).
The current directors of Glaxosmithkline Asia Private Limited are:
- Nitin Mathur - Whole-Time Director
- Anurita Chopra - Whole-Time Director
- Ramesh Chander Gupta - Director
- Kanika Shah Wadhwa - Whole-Time Director
The primary industry of Glaxosmithkline Asia Private Limited is healthcare. The company specifically operates in ayurvedic products and services. The company is currently active in this sector.
Glaxosmithkline Asia Private Limited can be reached at the registered office: Patiala Road Nabha, Punjab, India – 147201, or through the website gsk.com.
The authorised capital is ₹10 Cr, and the paid-up capital is ₹5.5 Cr.